Regulation of lipid metabolism by sphingolipids

Subcellular Biochemistry

Volumn 49, Issue , 2008, Pages 371-385

  Worgall, Tilla S ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Ceramide; Cholesterol; Serine palmitoyl transferase; Sphingomyelin; SREBP

Indexed keywords

CHOLESTEROL; LIPOPROTEIN; PHOSPHATIDYLCHOLINE CERAMIDE PHOSPHOCHOLINE TRANSFERASE; PHOSPHATIDYLCHOLINE-CERAMIDE PHOSPHOCHOLINE TRANSFERASE; PHOSPHOTRANSFERASE; SPHINGOLIPID; SPHINGOMYELIN; STEROL REGULATORY ELEMENT BINDING PROTEIN; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID;

ANIMAL; ANIMAL MODEL; BIOSYNTHESIS; BLOOD; CARDIOVASCULAR DISEASE; DRUG EFFECT; GENE EXPRESSION REGULATION; HUMAN; LIPID METABOLISM; LIPIDOSIS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; RISK;

ANIMALS; CARDIOVASCULAR DISEASES; CHOLESTEROL; FATTY ACIDS, UNSATURATED; GENE EXPRESSION REGULATION; HUMANS; LIPID METABOLISM; LIPOPROTEINS; MODELS, ANIMAL; RISK; SPHINGOLIPIDOSES; SPHINGOLIPIDS; SPHINGOMYELINS; STEROL REGULATORY ELEMENT BINDING PROTEINS; TRANSFERASES (OTHER SUBSTITUTED PHOSPHATE GROUPS);

EID: 58149280847     PISSN: 03060225     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4020-8830-8_14     Document Type: Article

References (60)

1. Abousalham A, Hobman TC, Dewald J, Garbutt M, Brindley DN. Cell-permeable ceramides preferentially inhibit coated vesicle formation and exocytosis in Chinese hamster ovary compared with Madin- Darby canine kidney cells by preventing the membrane association of ADP- ribosylation factor. Biochem J 361(2002) 653-661.
2. Arimoto I, Saito H, Kawashima Y, Miyajima K, Handa T. Effects of sphingomyelin and cholesterol on lipoprotein lipase-mediated lipolysis in lipid emulsions. J Lipid Res 39(1998) 143-151.
3. Baron CL, Malhotra V. Role of diacylglycerol in PKD recruitment to the TGN and protein transport to the plasma membrane. Science 295(2002) 325-328.
4. Batheja AD, Uhlinger DJ, Carton JM, Ho G, D'Andrea MR. Characterization of serine palmitoyltransferase in normal human tissues. J Histochem Cytochem 51(2003) 687-696.
5. Baumgart T, Hess ST, Webb WW. Imaging coexisting fluid domains in biomembrane models coupling curvature and line tension. Nature 425(2003) 821-824.
6. Bolin DJ, Jonas A. Sphingomyelin inhibits the lecithin-cholesterol acyltransferase reaction with reconstituted high density lipoproteins by decreasing enzyme binding. J Biol Chem 271(1996) 19152-19158.
7. Demel RA, Jansen JW, van Dijck PW, van Deenen LL. The preferential interaction of cholesterol with different classes of phospholipids. Biochim Biophys Acta 465(1977) 1-10.
8. Dobrosotskaya IY, Seegmiller AC, Brown MS, Goldstein JL, Rawson RB. Regulation of SREBP processing and membrane lipid production by phospholipids in Drosophila. Science 296(2002) 879-883.
9. Dong J, Liu J, Lou B, Li Z, Ye X, Wu M, Jiang XC. Adenovirus-mediated overexpression of sphingomyelin synthases 1 and 2 increases the atherogenic potential in mice. J Lipid Res 47(2006) 1307-1314.
10. Fugmann T, Hausser A, Schoffler P, Schmid S, Pfizenmaier K, Olayioye MA. Regulation of secretory transport by protein kinase D-mediated phosphorylation of the ceramide transfer protein. J Cell Biol 178(2007) 15-22.
11. Ghering AB, Davidson WS. Ceramide structural features required to stimulate ABCA1- mediated cholesterol efflux to apolipoprotein A-I. J Lipid Res 47(2006) 2781-2788.
12. Glaros EN, Kim WS, Quinn CM, Wong J, Gelissen I, Jessup W, Garner B. Glycosphingolipid accumulation inhibits cholesterol efflux via the ABCA1/apolipoprotein A-I pathway: 1-phenyl-2-decanoylamino-3-morpholino-1-propanol is a novel cholesterol efflux accelerator. J Biol Chem 280(2005) 24515-24523.
13. Hanada K. Discovery of the molecular machinery CERT for endoplasmic reticulum-to-Golgi trafficking of ceramide. Mol Cell Biochem 286(2006) 23-31.
14. Hanada K, Kumagai K, Yasuda S, Miura Y, Kawano M, Fukasawa M, Nishijima M. Molecular machinery for non-vesicular trafficking of ceramide. Nature 426(2003) 803-809.
15. Hannun YA, Obeid LM. The Ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind. J Biol Chem 277(2002) 25847-25850.
16. Hojjati MR, Li Z, Jiang XC. Serine palmitoyl-CoA transferase (SPT) deficiency and sphingolipid levels in mice. Biochim Biophys Acta 1737(2005a) 44-51.
17. Hojjati MR, Li Z, Zhou H, Tang S, Huan C, Ooi E, Lu S, Jiang XC. Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice. J Biol Chem 280(2005b) 10284-10289.
18. Hornemann T, Richard S, Rutti MF, Wei Y, von Eckardstein A. Cloning and initial characterization of a new subunit for mammalian serine-palmitoyltransferase. J Biol Chem 281(2006) 37275-37281.
19. Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109(2002) 1125-1131.
20. Horton JD, Shah NA, Warrington JA, Anderson NN, Park SW, Brown MS, Goldstein JL. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc Natl Acad Sci U S A 100(2003) 12027-12032.
21. Huitema K, van den Dikkenberg J, Brouwers JF, Holthuis JC. Identification of a family of animal sphingomyelin synthases. Embo J 23(2004) 33-44.
22. Jeong T, Schissel SL, Tabas I, Pownall HJ, Tall AR, Jiang X. Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase. J Clin Invest 101(1998) 905-912.
23. Jiang XC, Paultre F, Pearson TA, Reed RG, Francis CK, Lin M, Berglund L, Tall A. Plasma sphingomyelin level as a risk factor for coronary artery disease. Arterioscler Thromb Vasc Biol 20(2000) 2614-2618.
24. Johnson RA, Hamilton JA, Worgall TS, Deckelbaum RJ. Free fatty acids modulate intermembrane trafficking of cholesterol by increasing lipid mobilities: novel 13C NMR analyses of free cholesterol partitioning. Biochemistry 42(2003) 1637-1645.
25. Kawano M, Kumagai K, Nishijima M, Hanada K. Efficient trafficking of ceramide from the endoplasmic reticulum to the Golgi apparatus requires a VAMP-associated protein-interacting FFAT motif of CERT. J Biol Chem 281(2006) 30279-30288.
26. Kunte AS, Matthews KA, Rawson RB. Fatty acid auxotrophy in Drosophila larvae lacking SREBP. Cell Metab 3(2006) 439-448.
27. Lahiri S, Futerman AH. LASS5 is a bona fide dihydroceramide synthase that selectively utilizes palmitoyl-CoA as acyl donor. J Biol Chem 280(2005) 33735-33738.
28. Lange Y, Swaisgood MH, Ramos BV, Steck TL. Plasma membranes contain half the phospholipid and 90% of the cholesterol and sphingomyelin in cultured human fibroblasts. J Biol Chem 264(1989) 3786-3793.
29. Le Stunff H, Giussani P, Maceyka M, Lepine S, Milstien S, Spiegel S. Recycling of sphingosine is regulated by the concerted actions of sphingosine-1-phosphate phosphohydrolase 1 and sphingosine kinase 2. J Biol Chem 282(2007) 34372-34380.
30. LeeCY, LesimpleA, Denis M, Vincent J, LarsenA,Mamer O, Krimbou L, Genest J,Marcil M. Increased sphingomyelin content impairs HDL biogenesis and maturation in human Niemann- Pick disease type B. J Lipid Res 47(2006) 622-632.
31. McGovern MM, Pohl-Worgall T, Deckelbaum RJ, Simpson W, Mendelson D, Desnick RJ, Schuchman EH, Wasserstein MP. Lipid abnormalities in children with types A and B Niemann Pick disease. J Pediatr 145(2004) 77-81.
32. McKay RM, McKay JP, Avery L, Graff JM. C elegans: a model for exploring the genetics of fat storage. Dev Cell 4(2003) 131-142.
33. Merrill AH, Jr., Sullards MC, Allegood JC, Kelly S, Wang E. Sphingolipidomics: highthroughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry. Methods 36(2005) 207-224.
34. Nelson JC, Jiang XC, Tabas I, Tall A, Shea S. Plasma sphingomyelin and subclinical atherosclerosis: findings from the multi-ethnic study of atherosclerosis. Am J Epidemiol 163(2006) 903-912.
35. Ohvo-Rekila H, Ramstedt B, Leppimaki P, Slotte JP. Cholesterol interactions with phospholipids in membranes. Prog Lipid Res 41(2002) 66-97.
36. Pagano RE, Puri V, Dominguez M, Marks DL. Membrane traffic in sphingolipid storage diseases. Traffic 1(2000) 807-815.
37. Park TS, Panek RL, Mueller SB, Hanselman JC, Rosebury WS, Robertson AW, Kindt EK, Homan R, Karathanasis SK, Rekhter MD. Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice. Circulation 110(2004) 3465-3471.
38. Park TS, Panek RL, Rekhter MD, Mueller SB, Rosebury WS, Robertson A, Hanselman JC, Kindt E, Homan R, Karathanasis SK. Modulation of lipoprotein metabolism by inhibition of sphingomyelin synthesis in ApoE knockout mice. Atherosclerosis 189(2006) 264-272.
39. Pewzner-Jung Y, Ben-Dor S, Futerman AH. When do Lasses (longevity assurance genes) become CerS (ceramide synthases)? Insights into the regulation of ceramide synthesis. J Biol Chem 281(2006) 25001-25005.
40. Puri V, Jefferson JR, Singh RD, Wheatley CL, Marks DL, Pagano RE. Sphingolipid storage induces accumulation of intracellular cholesterol by stimulating SREBP-1 cleavage. J Biol Chem 278(2003) 20961-20970.
41. Ridgway ND. 25-Hydroxycholesterol stimulates sphingomyelin synthesis in Chinese hamster ovary cells. J Lipid Res 36(1995) 1345-1358.
42. Ridgway ND, Merriam DL. Metabolism of short-chain ceramide and dihydroceramide analogues in Chinese hamster ovary (CHO) cells. Biochim Biophys Acta 1256(1995) 57-70.
43. Rosenwald AG, Pagano RE. Inhibition of glycoprotein traffic through the secretory pathway by ceramide. J Biol Chem 268(1993) 4577-4579.
44. Sakai J, Duncan EA, Rawson RB, Hua X, Brown MS, Goldstein JL. Sterol-regulated release of SREBP-2 from cell membranes requires two sequential cleavages, one within a transmembrane segment. Cell 85(1996) 1037-1046.
45. Schaefer EJ, Lamon-Fava S, Ordovas JM, Cohn SD, Schaefer MM, Castelli WP, Wilson PW. Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study. J Lipid Res 35(1994) 871-882.
46. Scheek S, Brown MS, Goldstein JL. Sphingomyelin depletion in cultured cells blocks proteolysis of sterol regulatory element binding proteins at site 1. Proc Natl Acad Sci U S A 94(1997) 11179-11183.
47. Schissel SL, Tweedie-Hardman J, Rapp JH, Graham G, Williams KJ, Tabas I. Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained lowdensity lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins. J Clin Invest 98(1996) 1455-1464.
48. Schuchmann EH, Desnick RJ: Niemann-Pick Diseases Type A and B: Acid sphingomyelinase deficiencies, Vol. 2. New York: McGraw Hill; (1995) 2601-2624.
49. Shayman JA, Lee L, Abe A, Shu L. Inhibitors of glucosylceramide synthase. Methods Enzymol 311(2000) 373-387.
50. Soccio RE, Breslow JL. StAR-related lipid transfer (START) proteins: mediators of intracellular lipid metabolism. J Biol Chem 278(2003) 22183-22186.
51. Sot J, Aranda FJ, Collado MI, Goni FM, Alonso A. Different effects of long-and short-chain ceramides on the gel-fluid and lamellar-hexagonal transitions of phospholipids: a calorimetric, NMR, and x-ray diffraction study. Biophys J 88(2005) 3368-3380.
52. Spassieva S, Seo JG, Jiang JC, Bielawski J, Alvarez-Vasquez F, Jazwinski SM, Hannun YA, Obeid LM. Necessary role for the Lag1p motif in (dihydro)ceramide synthase activity. J Biol Chem 281(2006) 33931-33938.
53. Tafesse FG, Ternes P, Holthuis JC. The multigenic sphingomyelin synthase family. J Biol Chem 281(2006) 29421-29425.
54. van Meer G. Lipid traffic in animal cells. Annu Rev Cell Biol 5(1989) 247-275.
55. Venkataraman K, RiebelingC, Bodennec J,Riezman H, Allegood JC, SullardsMC,MerrillAH, Jr., Futerman AH. Upstream of growth and differentiation factor 1 (uog1), a mammalian homolog of the yeast longevity assurance gene 1 (LAG1), regulates N-stearoyl-sphinganine (C18-(dihydro)ceramide) synthesis in a fumonisin B1-independent manner in mammalian cells. J Biol Chem277(2002) 35642-35649.
56. Witting SR, Maiorano JN, Davidson WS. Ceramide enhances cholesterol efflux to apolipoprotein A-I by increasing the cell surface presence of ATP-binding cassette transporter A1. J Biol Chem 278(2003) 40121-40127.
57. Worgall TS, Sturley SL, Seo T, Osborne TF, Deckelbaum RJ. Polyunsaturated fatty acids decrease expression of promoters with sterol regulatory elements by decreasing levels of mature sterol regulatory element-binding protein. J Biol Chem 273(1998) 25537-25540.
58. Worgall TS, Juliano RA, Seo T, Deckelbaum RJ. Ceramide synthesis correlates with the posttranscriptional regulation of the sterol-regulatory element-binding protein. Arterioscler Thromb Vasc Biol 24(2004a) 943-948.
59. Worgall TS, Davis-Hayman SR, MaganaMM,Oelkers PM, Zapata F, Juliano RA,Osborne TF, Nash TE, Deckelbaum RJ. Sterol and fatty acid regulatory pathways in a Giardia lambliaderived promoter: evidence for SREBP as an ancient transcription factor. J Lipid Res 45(2004b) 981-988.
60. Zanolari B, Friant S, Funato K, Sutterlin C, Stevenson BJ, Riezman H. Sphingoid base synthesis requirement for endocytosis in Saccharomyces cerevisiae. Embo J 19(2000) 2824-2833.